Difference between revisions of "Buserelin (Suprefact)"
Jump to navigation
Jump to search
(Created page with "==Mechanism of action== Gonadotropin-releasing hormone (GnRH) analog, inhibits pituitary gonadotropin secretion, which suppresses ovarian and testicular steroidogenesis. ==Di...") |
m |
||
| Line 4: | Line 4: | ||
==Diseases for which it is used== | ==Diseases for which it is used== | ||
*[[Prostate cancer]] | *[[Prostate cancer]] | ||
| + | |||
| + | ==Also known as== | ||
| + | *'''Code names:''' HOE 766, ICI 123215, S74-6766 | ||
| + | *'''Brand names:''' Bigonist, Etilamide, Profact, Receptal, Suprecur, Suprefact | ||
[[Category:Prostate cancer medications]] | [[Category:Prostate cancer medications]] | ||
[[Category:Stub]] | [[Category:Stub]] | ||
Revision as of 12:33, 4 December 2022
Mechanism of action
Gonadotropin-releasing hormone (GnRH) analog, inhibits pituitary gonadotropin secretion, which suppresses ovarian and testicular steroidogenesis.
Diseases for which it is used
Also known as
- Code names: HOE 766, ICI 123215, S74-6766
- Brand names: Bigonist, Etilamide, Profact, Receptal, Suprecur, Suprefact